
A new report from Americans for Tax Fairness concludes:
“In addition to dodging its fair share of taxes, Pfizer—maker of Celebrex, Lipitor, Lyrica, and Viagra, among many other health-care products—has also been aggressively raising prescription drug prices, thereby straining patients and our health care system and in some cases putting needed medications out of reach.
By dodging taxes while boosting prescription drug prices, Pfizer squeezes American families and communities from two sides at once. In the company’s biggest insult to America yet, Pfizer’s merger will allow it to go on enjoying all the benefits of being based here—everything from a publicly educated workforce to an excellent communications infrastructure to a reliable patent system—without adequately paying to support them.”
The two wealth-extracting techniques go together, very often. This is what modern capitalism is increasingly becoming.
Why doesn’t Pfizer’s leadership focus on what it was originally set up to do: wealth creation? And don’t get us started on shareholder value.
Related articles

UN tax convention hub – updates & resources
What should we be worried about? Estimating bilateral illicit financial risk envelopes for major developed and developing economies
10 November 2026
What does the global FDI network actually look like? Opening the black box of offshore investment
10 November 2026
Mapping illicit financial networks linked to actors in countries with weak rule of law: A global investment census approach
10 November 2026

Indicator deep dive: Reporting of tax avoidance schemes

The ‘wealth exodus’ was manufactured by the press. The press complaints body IPSO must investigate or step aside.

Review: Bloomberg’s reporting of an exodus of billionaires worth $160 billion does not hold

Launching a new tool to reveal the global extent of illicit financial flows and how to tackle them

UN Framework Convention – Roundup of the Fifth Session of Negotiations
Notes on the UN tax convention draft protocol on dispute prevention and resolution
11 September 2026
